Telemetry Investments’s Pear Therapeutics, Inc. Warrant PEARW Stock Holding History

Telemetry Investments’s Portfolio PEARW Stock Details PEARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$13K	Hold	85,742	–	–	0.02%	108
2022 Q3	$15K	Hold	85,742	–	–	0.02%	135
2022 Q2	$10K	Hold	85,742	–	–	0.01%	157
2022 Q1	$68K	Buy	85,742 +240	+0.3%	+$168	0.11%	113
2021 Q4	$51K	Sell	85,502 -40,000	-32%	-$40.6K	0.07%	160
2021 Q3	$119K	Buy	125,502 +52,131	+71%	+$54.3K	0.16%	116
2021 Q2	$103K	Buy	+73,371	New	+$64K	0.14%	110

Other funds holding PEARW

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

OCAM

Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return

DCM

Difesa Capital Management New York $38.1M AUM 39.86% 1-Year Est. Return

AGC

Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return

QGA

Q Global Advisors Fort Worth, Texas $113M AUM 20.91% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return

SRF

Silver Rock Financial Los Angeles, California $49.7M AUM 17.42% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Telemetry Investments's PEARW Position: Q4 2022 in Review

Telemetry Investments held its Pear Therapeutics, Inc. Warrant (PEARW) position steady in Q4 2022 at 85,742 shares worth $13K. The position accounts for 0.02% of the portfolio, ranked #108.

Telemetry Investments first reported a position in PEARW in Q2 2021 and has held it in 7 quarters since. The position peaked at $119K in Q3 2021. 33 funds tracked by Wall St. Rank hold PEARW as of Q4 2022.

Telemetry Investments held 85,742 shares of Pear Therapeutics, Inc. Warrant worth $13K as of Q4 2022.
Telemetry Investments left its Pear Therapeutics, Inc. Warrant share count unchanged in Q4 2022.
Pear Therapeutics, Inc. Warrant made up 0.02% of Telemetry Investments's portfolio in Q4 2022, its #108 holding.
Telemetry Investments first reported a position in Pear Therapeutics, Inc. Warrant in Q2 2021 and has held it in 7 quarters since.
Telemetry Investments's Pear Therapeutics, Inc. Warrant position peaked at $119K in Q3 2021.
33 funds tracked by Wall St. Rank held Pear Therapeutics, Inc. Warrant as of Q4 2022.

Based on Telemetry Investments's 13F filing for Q4 2022, filed 14 Feb 2023.